Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
PepsiCo
PEP
$172B
| $16.8M | 0.01% |
126,826
-956,178
| -88% | -$126M |
2013 Q2
28 quarters
|
|
|
EGRX
927
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $16.8M | 0.01% |
349,500
+60,900
| +21% | +$3.04M |
2019 Q3
3 quarters
|
|
928
Americold
COLD
$3.99B
| $16.8M | 0.01% |
461,700
+279,500
| +153% | +$9.55M |
2018 Q3
7 quarters
|
|
929
TC Energy
TRP
$62.6B
| $16.7M | 0.01% |
392,203
+359,203
| +1,088% | +$16.1M |
2013 Q2
28 quarters
|
|
930
NorthWestern Energy
NWE
$4.56B
| $16.7M | 0.01% |
306,926
-37,904
| -11% | -$2.2M |
2016 Q3
15 quarters
|
|
931
KRONOS Worldwide
KRO
$876M
| $16.7M | 0.01% |
1,606,700
-28,300
| -2% | -$265K |
2016 Q1
17 quarters
|
|
932
OceanFirst Financial
OCFC
$1.55B
| $16.7M | 0.01% |
946,917
-56,500
| -6% | -$905K |
2013 Q2
28 quarters
|
|
933
Columbia Financial
CLBK
$2.91B
| $16.7M | 0.01% |
2,630,610
+405,020
| +18% | +$2.57M |
2019 Q2
4 quarters
|
|
934
Mine Safety
MSA
$6.97B
| $16.7M | 0.01% |
+145,800
| New | +$16.2M |
2020 Q2
0 quarters
|
|
|
PDCO
935
DELISTED
Patterson Companies, Inc.
PDCO
| $16.6M | 0.01% |
755,304
+679,060
| +891% | +$11.9M |
2018 Q1
9 quarters
|
|
936
Powell Industries
POWL
$6.99B
| $16.6M | 0.01% |
1,818,405
-72,000
| -4% | -$612K |
2015 Q3
19 quarters
|
|
937
Heartland Express
HTLD
$860M
| $16.6M | 0.01% |
795,627
+144,300
| +22% | +$2.9M |
2018 Q4
6 quarters
|
|
938
Buckle
BKE
$2.27B
| $16.6M | 0.01% |
1,056,150
-476,061
| -31% | -$7.13M |
2019 Q2
4 quarters
|
|
939
KNOT Offshore Partners
KNOP
$356M
| $16.5M | 0.01% |
1,200,304
-258,200
| -18% | -$3.54M |
2016 Q2
16 quarters
|
|
940
Knight Transportation
KNX
$10.5B
| $16.5M | 0.01% |
+394,727
| New | +$15.1M |
2020 Q2
0 quarters
|
|
941
Euronet Worldwide
EEFT
$2.42B
| $16.5M | 0.01% |
171,745
-92,800
| -35% | -$8.57M |
2019 Q3
3 quarters
|
|
942
Marriott Vacations Worldwide
VAC
$3.62B
| $16.3M | 0.01% |
198,861
+141,800
| +249% | +$11.6M |
2020 Q1
1 quarter
|
|
943
SEI Investments
SEIC
$12.6B
| $16.2M | 0.01% |
294,926
-601,500
| -67% | -$31.4M |
2017 Q2
12 quarters
|
|
944
Southwest Gas
SWX
$6.1B
| $16.1M | 0.01% |
+233,500
| New | +$17M |
2020 Q2
0 quarters
|
|
945
Chefs' Warehouse
CHEF
$4.66B
| $16.1M | 0.01% |
1,184,100
+37,500
| +3% | +$518K |
2017 Q3
11 quarters
|
|
946
Wabash National
WNC
$538M
| $16.1M | 0.01% |
1,512,400
+369,300
| +32% | +$3.25M |
2018 Q2
8 quarters
|
|
947
Allegion
ALLE
$12.8B
| $16.1M | 0.01% |
157,100
-278,700
| -64% | -$27.5M |
2019 Q2
4 quarters
|
|
948
Artesian Resources
ARTNA
$347M
| $16M | 0.01% |
440,111
+28,861
| +7% | +$1.01M |
2013 Q2
28 quarters
|
|
|
ATCO
949
DELISTED
Atlas Corp.
ATCO
| $16M | 0.01% |
2,099,307
-280,800
| -12% | -$2.04M |
2018 Q2
8 quarters
|
|
950
iRadimed
IRMD
$1.12B
| $15.9M | 0.01% |
686,357
+60,200
| +10% | +$1.29M |
2017 Q3
11 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.